SAN DIEGO, April 25, 2013 /PRNewswire/ — CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation…
CareFusion Expects $41M Will Settle ChloraPrep® Skin Prep Sales & Marketing Allegations
CareFusion Corp. has announced an agreement in principle to resolve previously disclosed government investigations related to prior sales and marketing practices for its ChloraPrep® skin preparation product and its relationships with health care professionals.